- Report
- January 2025
Austria
From €1314EUR$1,500USD£1,140GBP
- Report
- January 2025
Australia
From €1314EUR$1,500USD£1,140GBP
- Report
- January 2025
Argentina
From €1314EUR$1,500USD£1,140GBP
- Report
- January 2025
Albania
From €1314EUR$1,500USD£1,140GBP
- Report
- March 2024
Czech Republic
From €1314EUR$1,500USD£1,140GBP
The Prothrombin Time (PT) market is a segment of the Coagulation and Hemostasis Testing industry. PT is a test used to measure the time it takes for a blood sample to clot, and is used to diagnose and monitor conditions such as hemophilia, liver disease, and vitamin K deficiency. PT tests are typically performed in a laboratory setting, and the results are used to determine the effectiveness of anticoagulant medications.
The PT market is highly competitive, with a variety of companies offering products and services. Major players in the market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Beckman Coulter. Other companies in the market include Ortho Clinical Diagnostics, Bio-Rad Laboratories, and Helena Laboratories. Show Less Read more